Comment on: Prior bariatric surgery in COVID-19 positive patients may be protective

In this issue of Surgery of Obesity and Related Diseases , the manuscript titled “Prior bariatric surgery in COVID-19 positive patients may be protective” reports a retrospective review of patients utilizing a COVID-19 database from a single, New York City based academic institution which compared two groups: a bariatric surgery group (n=124) and a control group comprised fr om patients eligible for bariatric surgery[1]. The bariatric surgery group comprised of Roux-en-Y Gastric Bypass (RYGB) (n=45, 36%), laparoscopic Sleeve Gastrectomy (LSG) (n=35, 28%) and laparoscopic adjustable gastric banding (LAGB) (n=44, 35%).
Source: Surgery for Obesity and Related Diseases - Category: Surgery Authors: Source Type: research